CELLJUVANT
LIVE

Serial Number

90894570

Owner

Seqirus Inc.

Attorney

Nancy Sabarra

Filing Date

Aug 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CELLJUVANT Trademark

Serial Number: 90894570

CELLJUVANT is a trademark filed by Seqirus Inc. on August 20, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Seqirus Inc. (84 trademarks)

475 Green Oaks Parkway
Holly Springs, NC 27540

Entity Type: 03

Trademark Details

Filing Date

August 20, 2021

Registration Date

Not Registered

Published for Opposition

March 21, 2023

Goods & Services

Scientific research in the nature of conducting clinical trials for pharmaceutical preparations; scientific research in the nature of conducting clinical trials for flu vaccines; providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development

Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics

vaccines; vaccines for human use; flu vaccines

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 20, 2025 EXRA
SOU EXTENSION 5 GRANTED
Nov 19, 2025 EX5G
SOU TEAS EXTENSION RECEIVED
Nov 17, 2025 EEXT
SOU EXTENSION 5 FILED
Nov 16, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 14, 2025 EX4G
SOU EXTENSION 4 FILED
May 13, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 13, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2025 EXRA
SOU EXTENSION 3 GRANTED
Feb 5, 2025 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 5, 2025 AITU
SOU EXTENSION 3 FILED
Nov 18, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 14, 2024 EX2G
SOU EXTENSION 2 FILED
May 14, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 15, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 15, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 15, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 16, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 20, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 20, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 20, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2022 CNRT
ASSIGNED TO EXAMINER
May 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 7, 2021 NWOS
NEW APPLICATION ENTERED
Aug 24, 2021 NWAP